DOVER, DE — August 1, 2017 — InvestorsHub NewsWire — Metatron (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce it has secured a deal that brings a line of full spectrum products into the Metatron line of CBD products.
Our newest addition to the CBD product line will add Edible Gummies,Candies,tinctures,oils as well as capsule forms of CBD products. Our CBD Candy and Gummies are infused and NOT dipped or coated and provide a full spectrum profile of all cannabinoids and terpenes naturally found within the highest grade, naturally high CBD, medicinal cannabis strains. We have the most potent and powerful THC free CBD formulations in the world. Our THC free full spectrum oils provide the largest amount of naturally present cannabinoids and diverse terpenoids in the world.
“This newest addition to the Metatron product line will expedite Metatron’s entry into the Cannabis Health and Wellness area by giving such a diverse product line to add to our CBD infused Coffee’s and Tea’s. This newest addition places us well into the mainstream of the burgeoning Cannabis business. This is a direction into profitability for the Company and will increase shareholder value he added.” stated CEO Joe Riehl.
Metatron will update soon on when and where these products can be purchased by the consuming public. Metatron has completed its new Corporate website and updates and company information can be found there. The completion of this website is just one more step in Metatron moving towards being a major player in the Cannabis Industry. Shareholders and potential investors can access the website here http:// metatroninc.com/
The company is also pleased to announce a formal offer to Buzzlink, a cannabis e-commerce platform for dispensaries and
consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares. For more information, please visit http:// metatroninc.com/series-b/ or http://www.metatronstock.com/.
Metatron approved investors can acquire Series B shares in blocks of various sizes and recently increased discounts. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares. Details available at http://metatroninc.com/series- b/ or http://www.metatronstock.com.
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390 Google Play: https://play.google.com/store/apps/developer? id=Metatron+Inc
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any
obligation to update information contained in any forward-looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.
Joe Riehl 302-861-0431 email@example.com
SOURCE: Metatron, Inc.